md-medicaldata

Authors

 

Aleksa D. Novaković¹, Mirjana Živojinov^1,3, Dejan Ivanov^2,3, Goran Đenadić<sup>4

1</sup>Univerzitetski klinički centar Vojvodine, Centar za patologiju i histologiju
²Univerzitetski klinički centar Vojvodine, Klinika za abdominalnu, endokrinu i transplantacionu hirurgiju
³Univerzitet u Novom Sadu, Medicinski fakultet Novi Sad, Srbija
⁴Služba za patološko-anatomsku dijagnostiku, Opšta bolnica “Dr Laza K. Lazarević”, Šabac, Srbija

 

UDK: 616.37-006(497.113)"2015/2019"

The paper was received / Rad primljen: 28.08.2023.

Accepted / Rad prihvaćen: 13.09.2023.

 

Correspondence to:

Aleksa D. Novaković,
Univerzitetski klinički centar Vojvodine
Centar za patologiju i histologiju
Hajduk Veljkova 1,
21137 Novi Sad, Srbija
e-mail: novakovic124.aleksa@icloud.com

 

 

Sažetak

 

 

Uvod. Maligni tumori pankreasa zbog velike stope morbiditeta i mortaliteta predstavljaju sve veći zdravstveni i socio-ekonomski problem kako u svetu, tako i u Srbiji. Cilj. Cilj rada je utvrditi zastupljenost i morfološke karakteristike prekanceroznih i tumorskih lezija pankreasa analizom petogodišnje serije slučajeva. Materijal i metode. Кorišćeni materijal su pločice operativnog materijala pankreasa i patohistološki nalazi iz arhive Centra za patologiju i histologiju Кliničkog centra Vojvodine. Analizirani su slučajevi od 2015. do 2019. godine. Materijal je mikroskopiran, fotografisan i podaci su statistički obrađeni u programu PSPP 1.0.1, primenom Pirsonovog χ2-testa i Кruskal - Valisovog N-testa. Analizirani su nalazi 164 pacijenta starosti 10-85 godina, od toga 96 muškog, a 68 ženskog pola. Rezultati. Nema statistički značajne razlike u broju tumora pankreasa u odnosu na posmatrane godine, a najveći broj tumora svake godine bio je maligan. Statistički je značajno više muškaraca obolelo od žena. Muškarci statistički značajno češće obolevaju od malignih tumora pankreasa u odnosu na žene. Statistički značajno je više obolelih pacijenata starosti 60-69 godina u odnosu na ostale starosne grupe. Pacijenti sa malignim tumorom su u proseku bili stariji od pacijenata sa drugim tipovima tumora. Zaključak. U posmatranom petogodišnjem periodu nije bilo statistički značajnog povećanja broja tumora pankreasa, niti statistički značajne razlike u broju tumora po godinama. Najveći broj tumora svake godine je bio maligan (T3N1, G2) i to statistički značajno češće kod muškaraca starosti 60-69 godina, u glavi pankreasa. Benigni tumori su bili najčešći kod žena mlađih od 40 godina, u repu pankreasa.

 

Ključne reči:

Pankreas; Maligni tumor; Benigni tumor; Pol; Starost

 

 

 

Abstract

 

Introduction. Malignant pancreatic tumors, due to the high rate of morbidity and mortality, are a growing health and socio-economic problem both in the world and in Serbia. The aim.The aim of this study is to determine the presence and morphological characteristics of pancreatic precancerous and tumorous lesions by analyzing a five-year case series. Material and methods.The material used are formalin-fixed paraffin-embedded sections of the pancreatic operative material and pathology reports from the archives of the Center for Pathology abd Histology of the Clinical Center of Vojvodina.Cases from years 2015 to 2019 were analyzed. The material was examined under the microscope, photographed and the data were statistically processed in PSPP 1.0.1 using Pearson's χ2-test and Kruskal-Wallis N-test. Pathology reports of 164 patients aged 10-85 years were analyzed, of which 96 were male and 68 were female. Results.There was no statistically significant difference in the number of pancreatic tumors between the observed years, with the largest number of tumors every year being malignant.There were statistically significantly more males than females with pancreatic tumors.Men are statistically significantly more likely to have malignant pancreatic tumors than women. There were statistically significant more patients with pancreatic tumors aged 60-69 years compared to other age groups. Patients with malignant tumors were on average older than patients with other types of tumors.Conclusion. During the 5-year period, there was no statistically significant increase in the number of pancreatic tumors, nor a statistically significant difference in the number of tumors per year. The largest number of tumors every year was malignant (T3N1, G2), statistically significantly more often in men aged 60-69 years, in the pancreatic head.Benign tumors were most common in women under the age of 40 in the tail of the pancreas

 

Key words:

Pancreas; Malignant tumor; Benign tumor; Sex; Age

 

 

 

 

References:

1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.
2. Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–705.
3. Institut za zaštitu zdravlja Srbije „Dr Milan Jovanović Batut“. Incidencija i mortalitet od raka u Centralnoj Srbiji. Beograd: Institut za zaštitu zdravlja Srbije „Dr Milan Jovanović Batut“; 2017.
4. Mijač M, Draganić V, Radonjić V. Anatomija čoveka – abdomen i karlica. Treće izdanje. Beograd: Savremena administracija; 2005. Poglavlje 4, Sadržaj peritonealne duplje abdomena; p.125-31.
5. Čukuranović RČ. Anatomija čoveka: abdomen. Drugo izdanje. Gnjilane: Sveti Sava; 2002. Poglavlje 4, Sadržaj peritoneumske šupljine abdomena; p.175-84.
6. Kumar V, Abbas AK, Aster JC. Robbins basic pathology. 10th edition. Philadelphia: Elsevier; 2017.
7. Кlem I, Ušaj SК, Živojinov M. Patologija digestivnog sistema. U: Budakov P, Eri Ž, urednici. Patologija. Novi Sad: Medicinski fakultet; 2017. p.204-7.
8. Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE. AJCC cancer staging manual. 8th edition. New York City: Springer International Publishing; 2018.
9. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumors of the digestive system. 4th edition. Geneva: WHO Press; 2010.
10. Campbell F, Verbeke CS. Pathology of the pancreas: a practical approach. London: Springer-Verlag; 2013.
11. Кovač D, Nola M. Bolesti pankreasa. U: Damjanov I, Jukić S, Nola M, urednici. Patologija. Zagreb: Medicinska naklada; 2009. p.479-93.
12. Atanacković M, Bacetić D, Basta-Jovanović G, Begić-Janeva A, Borićić I, Brašanac D i dr. Patologija. Peto izdanje. Beograd: Medicinski fakultet Univerziteta; 2015.
13. Beger HG, Nakao A, Neoptolemos JP, Peng SY, Sarr MG. Pancreatic cancer, cystic neoplasms and endocrine tumors: diagnosis and management. Hoboken: John Wiley & Sons; 2015.
14. Cruickshank AH, Benbow EW. Pathology of the pancreas. 2nd edition. Heidelberg: Springer-Verlag; 1995.
15. Capasso M, Franceschi M, Rodriguez-Castro KI, Crafa P, Cambiè G, Miraglia C, et al. Epidemiology and risk factors of pancreatic cancer. Acta Biomed. 2018;89(9-S):141–6.
16. Krejs GJ. Pancreatic cancer: epidemiology and risk factors. Dig Dis. 2010;28(2):355-8.
17. Zhang Q, Zeng L, Chen Y, Lian G, Qian C, Chen S, et al. Pancreatic cancer epidemiology, detection, and management. Gastroenterol Res Pract. 2016;2016:8962321.
18. Crippa S, Salvia R, Warshaw AL,Domínguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247(4):571–9.
19. Zamboni G, Scarpa A, Bogina G,Iacono C, Bassi C, TalaminiG, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23(4):410–22.
    

PDF: 01-Novaković D. A. et al MD-Medical Data 2023;15(3) 067-071.pdf